ARCHIVES

Group trials need prioritization, review, NCI official says.

This article is from The Cancer Letter archive.

Vol. 29 No. 30 | July 25, 2003

Download PDF Visit The Full Archive

Related Articles

In Brief: GM awards Shared By Six Scientists; Pollard Named President of Salk Institute

June 21, 1996

Arzerra Given Accelerated Approval For Leukemia

October 30, 2009

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

June 24, 2011

Xgeva Significantly Increases Bone Metastasis-Free Survival

May 27, 2011

New Awards for New Investigators To Replace R-23 Grants

November 8, 1985

NCI Cooperative Group Clinical Trials Approved

April 30, 2010